Speciation of aluminum in biological systems

Journal of Toxicology and Environmental Health

Volumn 48, Issue 6, 1996, Pages 543-568

  Harris, Wesley R ^a   Berthon, Guy ^b   Day, J Philip ^c   Exley, Chris ^d   Flaten, Trond Peder ^e   Forbes, William F ^f   Kiss, Tamas ^g   Orvig, Chris ^h   Zatta, Paolo F ⁱ  

^a UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^b INSERM   (France)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d KEELE UNIVERSITY   (United Kingdom)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f UNIVERSITY OF WATERLOO   (Canada)

^g UNIVERSITY OF DEBRECEN   (Hungary)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALUMINUM; CITRIC ACID; PHOSPHATE; SILICATE; TRANSFERRIN;

BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; CONFERENCE PAPER; FRACTIONATION; HUMAN; MASS SPECTROMETRY; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; TOXICOKINETICS; WATER QUALITY;

ALUMINUM; ANIMALS; ANIONS; BRAIN DISEASES; CARRIER PROTEINS; CATIONS; CITRATES; ENVIRONMENTAL EXPOSURE; HUMANS; MODELS, BIOLOGICAL; SILICATES; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

EID: 0029818531     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/009841096161069     Document Type: Article

References (132)

1. Akitt, J. W., and Elders, J. M. 1988. Multinuclear magnetic resonance studies of hydrolysis of aluminum(III). Part 8. Base hydrolysis monitored at very high magnetic field. J. Chem. Soc. Dalton Trans. 1347-1355.
2. Alliey, N., Biron, F., Venturini-Soriano, M., and Berthon, G. 1995. A reinvestigation of alu-minum-phosphate equilibria under physiological conditions. Preliminary results. J. Inorg. Biochem. 59:241.
3. Alliey, N., Venturini-Soriano, M., and Berthon, G. 1996. Aluminum-succinate complex equilibria and their potential implications for aluminum metabolism. Ann. Clin. Lab. Sci. 26:122-132.
4. Atkari, K. 1994. Interactions of aluminum(III) with biologically important phosphates. PhD dissertation, Kossuth University.
5. Baes, C. F., and Mesmer, R. E. 1976. The hydrolysis of cations. New York: Wiley.
6. Bellia, J. P., Newton, K., Davenport, A., Birchall, J. D., and Roberts, N. B. 1994. Silicon and aluminium and their inter-relationship in serum and urine after renal transplantation. Eur. J. Clin. Invest. 24:703-710.
7. Bertholf, R. L., Wills, M. R., and Savory, J. 1984. Quantitative study of aluminum binding to human serum albumin and transferrin by a chelex competitive binding assay. Biochem. Biophys. Res. Commun. 125:1020-1024.
8. Berthon, G. 1996. Chemical speciation studies in relation to aluminum metabolism and toxicity. Coord. Chem. Rev., in press.
9. Berthon, G., and Dayde, S. 1992. Why aluminum phosphate is less toxic than aluminum hydroxide. J. Am. Coll. Nutr. 11:340-348.
10. Birchall, J. D., Exley, C., Chappell, J. S., and Phillips, M. J. 1989. Acute toxicity of aluminium to fish eliminated in silicon-rich acid waters. Nature 338:146-148.
11. Blanco Gonzalez, E., Parajon, J. P., Alonso, J. I. G., and Sanz-Medel, A. 1989. Analytical approaches to the problem of protein binding of aluminum in blood serum. J. Anal. Atomic Spectrosc. 4:175-179.
12. Browne, B. A., and Driscoll, C. T. 1992. Soluble aluminum silicates: Stoichiometry, stability, and implications for environmental geochemistry. Science 256:1667-1670.
13. Candy, J. M., Klinowski, J., Perry, R. H., Perry, E. K., Fairbairn, A., Oakley, A. E., Carpenter, T. A., Atack, J. R., Blessed, G., and Edwardson, J. A. 1986. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet i:354-357.
14. Chadwick, D. J., and Whelan, J., eds. 1992. Aluminum in biology and medicine. Ciba Foundation Symposium, vol. 169. New York: Wiley.
15. Chasteen, N. D. 1977. Human serotransferrin: Structure and function. Coord. Chem. Rev. 22:1-36.
16. Chasteen, N. D., and Williams, J. 1981. The influence of pH on the equilibrium distribution of iron between the metal-binding sites of human transferrin. Biochem. J. 193:717-727.
17. 2-microglobulin amyloid synovial tissue and articular cartilage. Nephron 65:559-563.
18. Clevette, D. J., and Orvig, C. 1990. Comparison of ligands of differing denticity and basicity for the in vivo chelation of aluminium and gallium. Polyhedron 9:151-161.
19. Cochran, M., Patterson, D., Neoh, S., Stevens, B., and Mazzachi, R. 1985. Binding of Al by protein in plasma of patients on maintenance hemodialysis. Clin. Chem. 31:1314-1316.
20. Cochran, M., Coates, J. H., and Kurucsev, R. 1987. Direct spectrophotometric determination of the two site binding of aluminum to transferrin. Life Sci. 40:2337-2341.
21. Davie, M. W. J., Worsfold, M., Sharp, C. A., Perks, J., and Day, J. P. 1993. Anomalous rise of serum osteocalcin following desferrioxamine treatment in aluminium intoxication. Nephron 65:245-248.
22. Day, J. P. 1986. Chemical aspects of aluminium chelation by desferrioxamine. In Aluminum and other trace elements in renal disease, ed. A. Taylor, pp. 184-192. London: Bailliere Tindall.
23. Day, J. P., Hewitt, C. D., and Ackrill, P. 1989. Chemistry and pharmacology of desferrioxamine as an aluminum chelator. In Aluminum and iron overload in haemodialysis, ed. M. E. De Broe, pp. 42-48. New York: Hogrefe & Huber.
24. Day, J. P., Barker, J., Evans, L. J. A., Perks, J., Seabright, P. J., Ackrill, P., Lilley, J. S., Drumm, P. V., and Newton, G. W. A. 1991. Aluminum absorption studied by 26-Al tracer. Lancet 337:1345.
25. Dayde, S., and Berthon, G. 1992. Potential role of tartaric acid towards aluminium metabolism. In Metal compounds in environment and life, eds. E. Marian and W. Haerdi, pp. 401-409. Northwood, UK: Science and Technology Letters.
26. Dayde, S., Venturini, M., and Berthon, G. 1989. Origin of the double role of citrate towards aluminum intoxication. J. Inorg. Biochem. 36:348.
27. Dayde, S., Filella, M., and Berthon, G. 1990. Aluminum speciation studies in biological fluids. Part 3. Quantitative investigation of aluminum-phosphate complexes and assessment of their potential significance in vivo. J. Inorg. Biochem. 38:241-259.
28. Domingo, J. L., Gomez, M., Llobet, J. M., and Corbella, J. 1991. Influence of some dietary constituents on aluminum absorption and retention in rats. Kidney Int. 39:598-601.
29. Domingo, J. L., Gomez, M., Sanchez, D. J., Llobet, J. M., and Corbella, J. 1993. Effect of various dietary constituents on gastrointestinal absorption of aluminum from drinking water and diet. Res. Commun. Chem. Pathol. Pharmacol. 79:377-380.
30. Duffield, J. R., Edwards, K., Evans, D. A., Morrish, D. M., Vobe, R. A., and Williams, D. R. 1991. Low molecular mass aluminum complex speciation in biofluids. J. Coord. Chem. 23:277-290.
31. Edwardson, J. A., Moore, P. B., Ferrier, I. N., Lilley, J. S., Newton, G. W. A., Barker, J., Templar, J., and Day, J. P. 1993. Effect of silicon on gastrointestinal absorption of aluminium. Lancet 342:211-212.
32. Evans, L. J. A., and Day, J. P. 1992. Interactions of aluminium and osteocalcin using aluminium-26 tracer and chromatographic studies. 19th Annual Meeting of the Federation of Analytical Chemistry and Spectroscopy Societies, Philadelphia, Abstr. 418.
33. Evans, P. H., Klinowski, J., Yano, F., and Urano, N. 1989. Alzheimer's disease: a pathogenic role for aluminosilicate-induced phagocytic free radicals. Free Radical Res. Comm. 6:317-321.
34. Evers, A., Hancock, R. D., Martell, A. E., and Motekaitis, R. J. 1989. Metal ion recognition in ligands with negatively charged oxygen donor groups. Complexation of Fe(III), Ga(III), In(III), Al(III), and other highly charged metal ions. Inorg. Chem. 28:2189-2195.
35. Exley, C., and Birchall, J. D. 1992. Hydroxyaluminosilicate formation in solutions of low total aluminium concentration. Polyhedron 11:1901-1907.
36. Exley, C., and Birchall, J. D. 1993. A mechanism of hydroxyaluminosilicate formation. Polyhedron 12:1007-1017.
37. Exley, C., and Birchall, J. D. 1995. Comment on "An assessment of complex formation between aluminium and silicic acid in acidic solutions." Geochim. Cosmochim. Acta 59:1017.
38. Exley, C., and Birchall, J. D. 1996. Silicon and the epidemiology of aluminum-related neurodegenerative disease. J. Theor. Biol., in press.
39. Exley, C., Price, N. C., and Birchall, J. D. 1994. Aluminum inhibition of hexokinase activity in vitro: a study in biological availability. J. Inorg. Biochem. 54:297-304.
40. Exley, C., Burgess, E., Day, J. P., Jeffery, E. H., Melethil, S., and Yokel, R. A. 1996. Aluminum toxicokinetics. J. Toxicol. Environ. Health 48:569-584.
41. Farmer, V. C., and Lumsdon, D. G. 1994. An assessment of complex formation between aluminum and silicic acid in acidic solutions. Geochim. Cosmochim. Acta 58:3331-3334.
42. Fasman, G. D., and Moore, C. D. 1994. The solubilization of model Alzheimer tangles: Reversing the p-sheet conformation induced by aluminum with silicates. Proc. Natl. Acad. Sci. USA 91:11232-11235.
43. Fasman, G. D., Perczel, A., and Moore, C. D. 1995. Solubilization of p-amyloid-(1-42)-peptide: Reversing the p-sheet conformation induced by aluminum with silicates. Proc. Natl. Acad. Sci. USA 92:369-371.
44. Fatemi, S. J. A., Kadir, F. H. A., and Moore, G. R. 1991. Aluminum transport in blood serum: Binding of aluminium by human transferrin in the presence of human albumin and citrate. Biochem.J. 280:527-532.
45. 3+ binding to small carboxylic acids and the proteins albumin and transferrin. J. Inorg. Biochem. 46:35-40.
46. 14C]sucrose in rats. Brain Res. 569:330-335.
47. Favarato, M., Mizzen, C. A., Sutherland, M. K., Krishnan, B., Kruck, T. P. A., and McLachlan, D. R. C. 1992a. Aluminum-binding serum proteins: Desferrioxamine alters serum aluminum speciation. Clin. Chim. Acta 207:41-55.
48. Favarato, M., Mizzen, C. A., and McLachlan, D. R. 1992b. Resolution of serum aluminum-binding proteins by size-exclusion chromatography: Identification of a new carrier of aluminum in human serum. J. Chromatogr. 576:271-285.
49. Fernandez-Martin, J. L., Menendez-Fraga, P., Canteros, M. A., Dfaz-Lopez, J. B., and Cannata-Andia, J. B. 1994. Binding of aluminium to plasma proteins: Comparative effect of desferrioxamine and deferiprone (L1). Clin. Chim. Acta 230:137-145.
50. Findlow, J. A., Duffield, J. R., and Williams, D. R. 1990. The chemical speclatlon of aluminum In milk. Chem. Spec. Bioavail. 2:3-32.
51. Flaten, T. P. 1990. Geographical associations between aluminium in drinking water and death rates with dementia (including Alzheimer's disease), Parkinson's disease, and amyotrophic lateral sclerosis in Norway. Environ. Geochem. Health 12:152-167.
52. Forbes, W. F., McAiney, C. A., Hayward, L. M., and Agwani, N. 1994. Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) II. The role of pH. Can. J. Aging 13:249-267.
53. Forbes, W. F., Gentleman, J. F., and Maxwel l, C. J. 1995a. Concerning the role of aluminum in causing dementia. Exp. Gerontology 30:23-32.
54. Forbes, W. F., Lessard, S., and Gentleman, J. F. 1995b. Geochemical risk factors for mental functioning, based on the Ontario longitudinal study of aging (LSA): V. Comparisons of the results, relevant to aluminum water concentrations, obtained from the LSA and death certificates mentioning dementia. Can. J. Aging 14:642-656.
55. Froment, D. P., Molitoris, B. A., Buddington, B., Miller, N., and Alfrey, A. C. 1989. Site and mechanism of enhanced gastrointestinal absorption of aluminum by citrate. Kidney Int. 36:978-984.
56. Ganrot, P. O. 1986. Metabolism and possible health effects of aluminum. Environ. Health Perspect. 65:363-441.
57. Garcia Alonso, J. I., Lopez Garcia, A., Perez Parajon, J., Blanco Gonzalez, E., Sanz Medel, A., and Cannata, J. B. 1990. High performance liquid chromatography methods for studying protein binding of aluminium in human serum in the absence and in the presence of des-ferrioxamine. Clin. Chim. Acta 189:69-79.
58. Gardiner, P. E., Stoeppler, M., and Nürnberg, H. W. 1984. The speciation of aluminium in human blood serum. In Trace element-analytical chemistry in medicine and biology, eds. P. Brätter and P. Schrämel, pp. 299-310. Berlin: Walter de Gruyter.
59. Gidden, H., Holland, F. F., and Klein, E. 1980. Trace metal protein binding in normal and dia-lyzed uremic serum. Trans. Am. Soc. Artificial Internal Organs 26:133-138.
60. Gomez, M., Domingo, J. L., del Castillo, D., Llobet, J. M., and Corbella, J. 1994. Comparative aluminum mobilizing actions of several chelators in aluminum-loaded uraemic rats. Hum. Exp. Toxicol. 13:135-139.
61. Graf, H., Stummvoll, H. K., Meisinger, V., Kovarik, J., Wolf, A., and Pinggera, W. F. 1981. Aluminum removal by hemodialysis. Kidney Int. 19:587-592.
62. 13C N.M.R. study. Aust. J. Chem. 39:1851-1864.
63. Harris, W. R. 1985. Thermodynamics of anion binding to human serum transferrin. Biochemistry 24:7412-7418.
64. Harris, W. R. 1992. Equilibrium model for speciation of aluminum in serum. Clin. Chem. 38:1809-1818.
65. Harris, W. R., and Sheldon, J. 1990. Equilibrium constants for the binding of aluminum to human serum transferrin. Inorg. Chem. 29:119-124.
66. Harris, W. R., Nesset-Tollefson, D., Stenback, J. Z., and Mohamed-Hani, N. 1990. Site selectivity in the binding of inorganic anions to serum transferrin. J. Inorg. Biochem. 38:175-183.
67. Hewitt, C. D., and Day, J. P. 1987. Separation of plasma proteins by high performance ionexchange chromatography to determine metal carrier proteins. In Trace elements in human health and disease: Extended abstracts. 2nd Nordic Symposium, Odense.
68. Hodson, M. J., and Evans, D. E. 1995. Aluminium/silicon interactions in higher plants. J. Exp. Bot. 46:161-171.
69. Hosakawa, S., Kohira, S., and Tomoyoshi, T. 1983. Aluminum transfer in chronic renal failure patients during hemodialysis. Blood Purification 1:62-69.
70. Jackson, G. E. 1990. Aluminium, gallium and indium in biological fluids—A computer model of blood plasma. Polyhedron 9:163-170.
71. Jackson, G. E., and Steyn, C. B. 1991. Studies on the chelation of aluminum for biological application. 3. Maltol. S. Afr. Tydsrk. Chem. 44:110-113.
72. Jackson, G. E., and Voyi, K. V. 1988. Studies on the chelation of aluminum for biological application. 3. Inorganic phosphate. S. Afr. J. Chem. 41:17-21.
73. Jones, M. M. 1985. An alternative model for the selection of therapeutic chelating agents. Inorg. Chim. Acta 107:235-241.
74. Jones, M. M., and May, P. M. 1987. The effect of kinetic factors on the thermodynamic evaluations of therapeutic agents. Inorg. Chim. Acta 138:67-73.
75. Kaehny, W. D., Hegg, A. P., and Alfrey, A. C. 1977. Gastrointestinal absorption of aluminum from aluminum-containing antacids. N. Engl. J. Med. 296:1389-1390.
76. Keirsse, H., Smeyers-Verbeke, J., Verbeelen, D., and Massart, D. L. 1987. Critical study of the speciation of aluminum in biological fluids by size-exclusion chromatography and electrothermal atomic absorption spectrometry. Anal. Chim. Acta 196:103-114.
77. Khalil-Manesh, F., Agness, C., and Gonick, H. C. 1989a. Aluminum-binding protein in dialysis dementia. II. Characterization in plasma by ultrafiltration. Nephron 52:329-333.
78. Khalil-Manesh, F., Agness, C., and Gonick, H. C. 1989b. Aluminum-binding protein in dialysis dementia. I. Characterization in plasma by gel chromatography and electrophoresis. Nephron 52:323-328.
79. King, S. W., Savory, J., and Wills, M. R. 1982. Aluminum distribution in serum following hemodialysis. Ann. Clin. Lab. Sci. 12:143-149.
80. Kiss, T., and Farkas, E. 1996. The bioinorganic chemistry of aluminum. In Perspectives in bioinorganic chemistry, eds. R. W. Hay, J. R. Dilworth, and K. B. Nolan, Chapter 4. London: Jai Press.
81. 3+ binding by adenosine 5'-phosphates: AMP, ADP, and ATP. Inorg. Chem. 30:2130-2132.
82. 3+ into the N-lobe of human serum transferrin. Biochem. J. 285:711-714.
83. Kubal, G., Sadler, P. J., and Evans, R. W. 1992b. Sequential binding of aluminum(3+) to the Cand N-lobes of human serum transferrin detected by H NMR spectroscopy. J. Am. Chem. Soc. 114:1117-1118.
84. Leung, F. Y., Hodsman, A. B., Muirhead, N., and Henderson, A. R. 1985. Ultrafiltration studies in vitro of serum aluminum in dialysis patients after deferioxamine chelation therapy. Clin. Chem. 31:20-23.
85. Leung, F. Y., Niblock, A. E., Bradley, C., and Henderson, A. R. 1988. Speciation studies of serum aluminum/citrate complex by liquid chromatography-furnace AAS. Sci. Total Environ. 71:49-56.
86. Lote, C. J., Wood, J. A., and Saunders, H. C. 1992. Renal filtration, reabsorption and excretion of aluminum in the rat. Clin. Sci. 82:13-18.
87. Maitani, T., Kubota, H., Hori, N., Yoshihira, K., and Takeda, M. 1994. Distribution and urinary excretion of aluminium injected with several organic acids into mice: Relationship with chemical state in serum studied by the HPLC-ICP method. J. Appl. Toxicol. 14:257-261.
88. Marques, H. M. 1991. Kinetics of the release of aluminum from human serum dialuminum transferrin to citrate. J. Inorg. Biochem. 41:187-193.
89. Martin, R. B. 1986a. The chemistry of aluminum as related to biology and medicine. Clin. Chem. 32:1797-1806.
90. 3+. J. Inorg. Biochem. 28:181-187.
91. Martin, R. B. 1988. Bioinorganic chemistry of aluminum. In Metal ions in biological systems, eds. H. Sigel and A. Sigel, vol. 24, pp. 1-57. New York: Marcel Dekker.
92. Martin, R. B. 1990. Aluminosilicate stabilities under blood plasma conditions. Polyhedron 9:193-197.
93. Martin, R. B. 1991. Aluminum in biological systems. In Aluminum in chemistry, biology and medicine, eds. M. Nicolini, P. F. Zatta, and B. Corain, pp. 3-20. New York: Raven Press.
94. Martin, R. B. 1994. Aluminum: A neurotoxic product of acid rain. Acc. Chem. Res. 27:204-210.
95. 3+. Clin. Chem. 33:405-407.
96. Martyn, C. N., Osmond, C., Edwardson, J. A., Barker, D. J. P., Harris, E. C., and Lacey, R. F. 1989. Geographical relation between Alzheimer's disease and aluminium In drinking water. Lancet i:59-62.
97. May, P. M. 1995. Applications of computer-aided speciation to bioinorganic medicine. Future trends. In Handbook of metal-ligand interactions in biological fluids: Bioinorganic chemistry, ed. G. Berthon, pp. 1291-1298. New York: Marcel Dekker.
98. May, P. M., Linder, P. W., and Williams, D. R. 1977. Computer simulation of metal-ion equilibria in biofluids: Models for the low-molecular-weight complex distribution of calcium(II), magnesium(II), iron(III), zinc(II), and lead(II) ions in human blood plasma. J. Chem. Soc. Dalton Trans. 588-595.
99. McLachlan, D. R. C. 1995. Aluminium and the risk for Alzheimer's disease. Environmetrics 6:233-275.
100. Molitoris, B. A., Froment, D. H., Mackenzie, T. A., Huffer, W. H., and Alfrey, A. C. 1989. Citrate: A major factor in the toxicity of orally administered aluminum compounds. Kidney Int. 36:949-953.
101. Moshtaghie, A. A., and Skillen, A. W. 1991. Desferrioxamine treatment in aluminum overload patients: an aluminum binding study. Indian J. Pharmacol. 23:75-80.
102. Motekaitis, R. J., and Martell, A. E. 1984. Complexes of aluminum(III) with hydroxy carboxylic acids. Inorg. Chem. 23:18-23.
103. Neri, L. C., and Hewitt, D. 1991. Aluminium, Alzheimer's disease and drinking water. Lancet 338:390.
104. Nieboer, E., and Richardson, D. H. S. 1980. The replacement of the nondescript term "heavy metals" by a biologically and chemically significant classification of metal ions. Environ. Pollut. B 1:3-26.
105. 3+-citric acid. Inorg. Chem. 27:2565-2570.
106. 3+ in serum. Clin. Chem. 40:598-601.
107. Ohman, L. O., and Sjoberg, S. 1983. Equilibrium and structural studies of silicon(IV) and alu-minium(III) in aqueous solution. 9. A potentiometric study of mono- and polynuclear alu-minium(III) citrates. J. Chem. Soc. Dalton Trans. 2513-2517.
108. Orvig, C. 1993. The aqueous coordination chemistry of aluminum. In The coordination chemistry of aluminum, ed. G. H. Robinson, pp. 85-121. New York: VCH.
109. Orvig, C., and Berthon, G. 1995. Speciation studies in relation to aluminum bioavailability. In Handbook of metal-ligand interactions in biological fluids: Bioinorganic chemistry, ed. G. Berthon, pp. 1266-1280. New York: Marcel Dekker.
110. Partridge, N. A., Regnier, F. E., White, J. L., and Hem, S. L. 1989. Influence of dietary constituents on intestinal absorption of aluminum. Kidney Int. 35:1413-1417.
111. Partridge, N. A., Regnier, F. E., Reed, W. M., White, J. L., and Hem, S. L. 1992. Contribution of soluble aluminium species to absorption of aluminium from the rat gut in situ. Clin. Sci. 83:425-430.
112. Perez Parajon, J., Blanco Gonzalez, E., Cannata, J. B., and Sanz Medel, A. 1989. A critical appraisal of the speciation of aluminum in serum by ultrafiltration. Trace Elem. Med. 6:41-46.
113. Peters, T. 1985. Serum albumin. Adv. Protein Chem. 37:161-245.
114. Powell, J. J., and Thompson, R. P. H. 1993. The chemistry of aluminium in the gastrointestinal lumen and its uptake and absorption. Proc. Nutr. Soc. 52:241-253.
115. Rahman, H., Skillen, A. W., Channon, S. M., Ward, M. K., and Kerr, D. N. S. 1985. Methods for studying the binding of aluminum by serum protein. Clin. Chem. 31:1969-1973.
116. Sadler, P. J., Tucker, A., and Viles, J. H. 1994. Involvement of a lysine residue in the N-termi-nal Ni + and Cu + binding site of serum albumins. Comparison with Co +, Cd + and Al +. Eur. J. Biochem. 220:193-200.
117. Sanz-Medel, A., and Fairman, B. 1992. Aluminum speciation: Clinical and environmental aspects. Mikrochim. Acta 109:157-160.
118. Shi, B., and Haug, A. 1990. Aluminum uptake by neuroblastoma cells. J. Neurochem. 55:551-558.
119. Slanina, P., Frech, W., Ekstrôm, L.-G., Lôôf, L., Slorach, S., and Cedergren, A. 1986. Dietary citric acid enhances absorption of aluminum in antacids. Clin. Chem. 32:539-541.
120. Sorenson, J. R. J., Campbell, I. R., Tepper, L. B., and Lingg, R. D. 1974. Aluminum in the environment and human health. Environ. Health Perspect. 8:3-95.
121. Tapparo, A., Solda, L., Bombi, G. G., Zambenedetti, P., Zatta, P., Bertani, R., and Corain, B. 1995. Analytical validation of a general protocol for the preparation of dose-controlled solutions in aluminum toxicology. Analyst 120:2425-2429.
122. Trapp, G. A. 1985. Aluminum binding to organic acids and plasma proteins. Implications for dialysis encephalopathy. J. Environ. Pathol. Toxicol. Oncol. 6:15-20.
123. van Ginkel, M. F., van der Voet, G. B., van Eijk, H. G., and de Wolff, F. A. 1990. Aluminum binding to serum constituents: A role for transferrin and for citrate. J. Clin. Chem. Clin. Biochem. 28:459-463.
124. Venturini, M., and Berthon, G. 1989. Aluminum speciation studies in biological fluids. Part 2. Quantitative investigation of aluminum-citrate complexes and appraisal of their potential significance in vivo. J. Inorg. Biochem. 37:69-90.
125. Vobe, R. A., and Williams, D. R. 1992. Chemical speciation of aluminium in blood plasma with reference to silica. Chem. Spec. Bioavail. 4:85-87.
126. Wills, M. R., and Savory, J. 1989. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity. Crit. Rev. Clin. Lab. Sci. 27:59-107.
127. Wrobel, K., Blanco González, E., and Sanz-Medel, A. 1994. Progress with the speciation of aluminum and silicon in serum of chronic renal patients using atomic spectroscopic techniques. J. Anal. Atomic Spectrosc. 9:281-284.
128. Yokel, R. A. 1994. Aluminum chelation: chemistry, clinical and experimental studies and the search for alternatives to desferrioxamine. J. Toxicol. Environ. Health 41:131-74.
129. Yokel, R. A., Datta, A. K., and Jackson, G. E. 1991. Evaluation of potential aluminum chelators in vitro by aluminum solubilization ability, aluminum mobilization from transferrin and the octanol/aqueous distribution of the chelators and their complexes with aluminum. J. Pharmacol. Exp. Ther. 257:100-106.
130. Zatta, P., Perazzolo, M., Facci, L., Skaper, S. D., Corain, B., and Favarato, M. 1992. Effects of aluminum speciation on murine neuroblastoma cells. Mol. Chem. Neuropathol. 16:11-22.
131. Zatta, P., Zambenedetti, P., Bruna, V., and Filippi, B. 1994a. Activation of acetylchol i nesterase by aluminium(III): The relevance of the metal species. NeuroReport 5:1777-1780.
132. Zatta, P., Zambenedetti, P., and Masiero, S. 1994b. Effects of aluminum lactate on murine neuroblastoma cells. Neurotoxicology 15:789-797.